Adam Havey

Chief Executive Officer at Emergent Travel Health, Inc.

Technology Services

Profile

Adam Havey is the founder of GuardLlama, Inc., which was founded in 2015.
He is currently the Chief Executive Officer at Emergent Travel Health, Inc.

Adam Havey active positions

Companies	Position	Start
Emergent Travel Health, Inc. Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.	Chief Executive Officer	-

All active positions of Adam Havey

Former positions of Adam Havey

Companies	Position	End
GuardLlama, Inc. GuardLlama, Inc. Packaged SoftwareTechnology Services Guard Llama, Inc. develops GPS location finder applications and devices. The company was founded by Dominick Blando, Joe Parisi and Havey Adam in 2015 and is headquartered in Chicago, IL.	Founder	-

See the detail of Adam Havey's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adam Havey's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
GuardLlama, Inc. GuardLlama, Inc. Packaged SoftwareTechnology Services Guard Llama, Inc. develops GPS location finder applications and devices. The company was founded by Dominick Blando, Joe Parisi and Havey Adam in 2015 and is headquartered in Chicago, IL.	Technology Services
Emergent Travel Health, Inc. Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.	Technology Services